Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
18.0%
% of WDNA's 91 holdings also in XDNA
69.6%
% of XDNA's 23 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in WDNA |
Weight in XDNA |
Overlap | |
---|---|---|---|---|
CRISPR THERAPEUTICS AG | 1.8% | 15.1% | 1.8% | |
CARIBOU BIOSCIENCES, INC. | 1.6% | 4.7% | 1.6% | |
EDITAS MEDICINE, INC. | 1.6% | 5.7% | 1.6% | |
BEAM THERAPEUTICS, INC. | 1.4% | 13.7% | 1.4% | |
VERTEX PHARMACEUTICALS INC | 1.3% | 1.5% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to XDNA
IOVANCE BIOTHERAPEUTICS INC | 3.9% | |
TWIST BIOSCIENCE CORP. | 3.4% | |
FATE THERAPEUTICS INC | 3.1% | |
NOVOZYMES A/S-B SHARES | 2.4% | |
BLUEPRINT MEDICINES CORP. | 2.2% | |
BRIDGEBIO PHARMA, INC. | 2.0% | |
NATERA INC | 1.9% | |
ELI LILLY & CO | 1.9% | |
ALCOBRA LTD | 1.7% | |
VERICEL CORPORATION | 1.7% |
WDNA Underweight Relative to XDNA
CRISPR THERAPEUTICS AG | -13.3% | |
BEAM THERAPEUTICS, INC. | -12.2% | |
THERMO FISHER SCIENTIFIC INC | -8.4% | |
INTELLIA THERAPEUTICS, INC. | -7.7% | |
PRIME MEDICINE, INC. | -5.9% | |
EDITAS MEDICINE, INC. | -4.1% | |
POSEIDA THERAPEUTICS, INC. | -4.1% | |
ABBVIE INC | -3.8% | |
VERVE THERAPEUTICS, INC. | -3.2% | |
SANOFI-AVENTIS | -3.2% |